Home
Conditions
Metastatic Colorectal Cancer

Clinical trial condition

Metastatic Colorectal Cancer

Explore clinical trials studying Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

393 public trials 73 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer trial results

Recruiting

ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

NCT06543836

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Sacituzumab Govitecan in Metastatic Colorectal Cancer

NCT06243393

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: University Hospital Heidelberg Heidelberg, Baden-Wurttemberg, Germany

View Trial Details

Recruiting

MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer

NCT05462236

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Prince of Wales Hospital Wollongong, New South Wales, Australia

Pindara Private Hospital, Gold Coast Cancer Care Benowa, Queensland, Australia

Cabrini Hospital Malvern, Victoria, Australia

View Trial Details

Recruiting

Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

NCT06485713

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Recruiting

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

NCT05229003

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

NCT06202001

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Recruiting

Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

NCT05007132

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Charité - Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Recruiting

Second-line Treatment of Metastatic Colorectal Cancer

NCT06242067

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Qilu hospital of Shandong University Jinan, Shandong, China

View Trial Details

Recruiting

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

NCT06218810

Conditions: Cadonilimab, Colonic Diseases, Colorectal Neoplasms, +12 more
Locations: Zhongshan hosptial, Fudan University Shanghai, China

View Trial Details

Recruiting

Sulfasalazine in Patients With Metastatic Colorectal Cancer

NCT06134388

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Tanta University Hospital Tanta, El-Gharbia Governorate, Egypt

View Trial Details

Metastatic Colorectal Cancer

Metastatic Colorectal Cancer trial results

Related conditions